LCTX earnings
Lineage Cell Therapeutics (LCTX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
LCTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | -0.03 | -0.03 | -5.01% | $1.43M |
| Q2 2026 | Aug 6, 2026 | -0.03 | -0.03 | -5.89% | $1.07M |
| Q1 2026 | May 12, 2026 | -0.03 | – | – | $1.73M |
| Q4 2025 | Mar 5, 2026 | 0.00 | – | – | $6.61M |
| Q3 2025 | Nov 6, 2025 | -0.13 | -0.02 | -550.00% | $3.68M |
| Q2 2025 | Aug 12, 2025 | -0.01 | -0.02 | 50.00% | $2.77M |
| Q1 2025 | May 13, 2025 | -0.02 | -0.02 | 0.00% | $1.50M |
| Q4 2024 | Mar 10, 2025 | -0.01 | -0.04 | 75.00% | $2.87M |
| Q3 2024 | Nov 14, 2024 | -0.02 | – | – | $3.78M |
| Q2 2024 | Aug 8, 2024 | -0.03 | -0.05 | 40.00% | $1.41M |
| Q1 2024 | May 9, 2024 | -0.04 | -0.04 | -4.36% | $1.44M |
| Q4 2023 | Mar 7, 2024 | -0.03 | -0.02 | -29.98% | $2.09M |
| Q3 2023 | Nov 9, 2023 | -0.04 | -0.04 | -6.67% | $1.25M |
| Q2 2023 | Aug 10, 2023 | -0.03 | -0.02 | -32.28% | $3.23M |
| Q1 2023 | May 11, 2023 | -0.03 | -0.02 | -21.75% | $2.39M |
| Q4 2022 | Mar 9, 2023 | -0.03 | -0.03 | -19.24% | $1.92M |
| Q3 2022 | Nov 10, 2022 | -0.04 | -0.04 | -14.29% | $3.00M |
- LCTX beat EPS estimates in 4 of its last 14 reports.
Updated 2026-11-17 17:46 UTC